- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has closed a one-year extension of the maturity date of its debenture. Mr. Donald McCaffrey, President and CEO stated, "We are very pleased that the debenture has been extended for one year, providing us with greater flexibility to create value for our shareholders through both our FDA approved BETonMACE2 final planning and our ongoing partnering discussions.” The maturity date of the Company’s US$12 million 10% secured convertible debenture (the “Debenture”), and payment of accrued interest thereon, has been extended by one year from September 26, 2020 to September 26, 2021. In connection with the extension, the holder, a wholly-owned subsidiary of ORI Star Fund LP, received 600,000 warrants exercisable until December 31, 2024 at a price of CAD$0.74 per share. About Resverlogixcom/news/resverlogix-secures-one-extension-maturity-110000760.html